Auchincloss has developed a special interest in treating patients with lung and pleural diseases such as malignant pleural mesothelioma.
More About
Hugh G. Auchincloss M.D. M.D.
Contact
Get in touch
He joined the Massachusetts General Hospital (MGH) Division of Thoracic Surgery in 2018, following in the footsteps of his father, Hugh Auchincloss Jr.
Auchincloss Jr., an international pioneer in the field of organ transplantation, operated a laboratory in transplantation immunology. He later served as the principal deputy director of the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health.
His son became a third-generation surgeon, establishing his own niche today with robotics and a minimally invasive approach to treating patients.
The benefits are a quicker post-surgery recovery, less postoperative pain and blood loss, shorter hospital stays, and a return to normal activities for the patients he serves.
Robotic surgery, which involves tiny instruments controlled remotely by a surgeon at a computer board, is used more extensively with lung cancer. With mesothelioma, it is more of a diagnostic tool.
The thoracic surgery program at MGH is part of a multidisciplinary team that designs an individualized plan for each patient it sees. The program is one of the most experienced in the world today at treating lung cancer with genetic mutations.
Clinical Interests Are Broad
His clinical interests also include esophageal cancer, gastroesophageal reflux disease, achalasia, thymoma, tumors of the mediastinum and the surgical treatment of myasthenia gravis.
Auchincloss graduated from Harvard Medical School, where his father once taught, in 2008. He completed his training in cardiothoracic surgery and general surgery at MGH.
He is a member of the American College of Surgeons, the General Thoracic Surgery Club and the Society of Thoracic Surgeons.
His work has been published in Journal of Thoracic Diseases, Annals of Thoracic Surgery, Shields’ General Thoracic Surgery 8th edition and Current Surgical Therapy.
